Navigation Links
Perrigo Vice Chair Mori Arkin To Retire After 30 Years of Service
Date:9/13/2007

ic Officer, who has more than 29 years of pharmaceutical leadership experience, will continue to manage Global R&D and Regulatory. Sharon Kochan, who has been with Perrigo more than 13 years, will continue in his role as EVP US Generics. Mr. Papa stated, "I am confident that Mori and his team will continue to manage the Perrigo Israel businesses well during this time of transition and I look forward to working directly with the team in the future."

Arkin said, "I have been proud to work with our leadership team to build Perrigo into the global company that it is today and to drive value for our shareholders. As a member of the board I will work with the leadership team, continuing the focus on key business initiatives and maintenance of the momentum we've established. I am committed to making this a smooth transition."

Perrigo Company is a leading global healthcare supplier that develops, manufactures and distributes over-the-counter (OTC) and prescription pharmaceuticals, nutritional products, active pharmaceutical ingredients (API) and consumer products. The Company is the world's largest manufacturer of OTC pharmaceutical products for the store brand market. The Company's primary markets and locations of manufacturing facilities are the United States, Israel, Mexico and the United Kingdom. Visit Perrigo on the Internet (http://www.perrigo.com).

Note: Certain statements in this press release are forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and are subject to the safe harbor created thereby. These statements relate to future events or the Company's future financial performance and involve known and unknown risks, uncertainties and other factors that may cause the actual results, levels of activity, performance or achievements of the Company or its industry to be materially different from those expressed or implied by any forward-l
'/>"/>

SOURCE Perrigo Company
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Perrigo Receives FDA Approval to Market Coated Fruit Nicotine Gum
2. New Chair Invented To Relieve Backache
3. Wood Appointed As the First Chair of SAADAT
4. ISB To Establish Research Chair On Real Estate And Urban Studies
5. Disabled Children Claims For NHS Funded Wheelchairs
6. Robot Wheelchair Maybe Helpful for Wheelchair-dependent Patients
7. Wheelchair Raises A Furore
8. Evidence Links Protein Damage to Neurodegenerative diseases like Parkinsons and Alzheimers
9. Drug Found To Bring Relief For Individuals With Early Parkinson’
10. Link between Constipation and Parkinsons Disease
11. Alternative therapies popular with Parkinsons patients

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)... wheezing, study finds , , TUESDAY, Nov.... traffic pollution and indoor endotoxin are at inc...toxin -- a component of bacteria believed to trigg...t. , University of Cincinnati College of Medici... warning sign of asthma and other lung conditions)...
(Date:11/24/2009)...g that testing less is OK , , TUESDAY, N...eening has been upended in the past two weeks. ,...orce (USPSTF) just raise the age at which it recom...0, but the American College of Obstetrics and Gyne...e spared the inconvenience and possible risks of c...
(Date:11/24/2009)...ire-FirstCall/--ICL(TASE:ICL),a,multinationalferti...sultsforthethirdquarterandninemonthsendedSeptember... , Revenues:Revenuesforthethirdquarterof2009w...1,083millionforthesecondquarterof,2009.Revenuesfor...theexceptionaldemandandpricesthatcharacterizedthat...
(Date:11/24/2009)...rkets build on their combined strength and momentu... Baltimore, Md. (PRWEB) November 24, 20...private equity firm based in Baltimore, Maryland, ...p.com ), a venture capital firm based in College P...ired Ecoast Sales Solutions, Ltd. ("eCoast&qu...
(Date:11/24/2009)...ld Volunteer Computing Team has joined the QMC@hom...Carlo method to problems in Quantum Chemistry. The...e science research. This project joins Folding@hom...vity wave detection), and GPUGrid (molecular biol... (PRWEB) November 24, 2009 -- GeoPense ...
Breaking Medicine News(10 mins):Health News:Traffic, Dust Linked to Asthma in Kids 2Health News:Recent Cancer Screening Changes Leave Many Confused 2Health News:Recent Cancer Screening Changes Leave Many Confused 3Health News:Recent Cancer Screening Changes Leave Many Confused 4Health News:ICL Reports Continued Sequential Improvement for Third Quarter of 2009 2Health News:ICL Reports Continued Sequential Improvement for Third Quarter of 2009 3Health News:ICL Reports Continued Sequential Improvement for Third Quarter of 2009 4Health News:ICL Reports Continued Sequential Improvement for Third Quarter of 2009 5Health News:ICL Reports Continued Sequential Improvement for Third Quarter of 2009 6Health News:ICL Reports Continued Sequential Improvement for Third Quarter of 2009 7Health News:Slate Capital Group and New Markets Venture Partners Acquire eCoast Sales Solutions 2Health News:Slate Capital Group and New Markets Venture Partners Acquire eCoast Sales Solutions 3Health News:GeoPense Announces it has Joined QMC@home Project 2
...Health Museum in Houston, Texas to be Site of Fac... May 30, 2009, the John P. McGovern Museum of Heal...useum, will launch the U.S. premiere of Facing Ma...d consider the implications humans face in their q...
... With the recent news that one in three ...thy lifestyle is more important than ever. Texans ...festyles than during busier times of the year. Tex...PRWEB) May 27, 2009 -- With the release of a recen...
...., May 27 , , Core News Facts : , , ...ty to interact with care providers online are lead...tients are taking a consumerist approach in choosi...gh American Recovery and Reinvestment Act for "mea...
...rned of side effect that could hamper immigration ...ws) -- The widely used cancer drug capecitabine ca...ould lead to problems when they,re trying to enter...he now advises people taking capecitabine to carry...
...ed at the Canadian-run military hospital in Kandah...vilian disasters, according to a London, Ontario p... Dr. Vivian McAlister is a professor in the Depar...es Centre. He spent two months working at the Kand...
...AGE, Colo., May 27 Recondo Technology, a leading ... care industry, today announced the firm,s selec...designating Recondo as one of the top 100 companie...newscom.com/cgi-bin/prnh/20090325/LA89162LOGO ) , ...
Other Medicine News:Health News:If You Could Travel to Mars, Would You Go? 2Health News:If You Could Travel to Mars, Would You Go? 3Health News:Fighting Preventable Cancers: Texas Oncology Encourages a Healthy Summer Lifestyle 2Health News:Fighting Preventable Cancers: Texas Oncology Encourages a Healthy Summer Lifestyle 3Health News:Fighting Preventable Cancers: Texas Oncology Encourages a Healthy Summer Lifestyle 4Health News:Fighting Preventable Cancers: Texas Oncology Encourages a Healthy Summer Lifestyle 5Health News:Greenway Medical Technologies' PrimePatient Solution Transforms Physician/Patient Relationship Through Enhanced Communication Channels and Improved Workflows 2Health News:Greenway Medical Technologies' PrimePatient Solution Transforms Physician/Patient Relationship Through Enhanced Communication Channels and Improved Workflows 3Health News:Greenway Medical Technologies' PrimePatient Solution Transforms Physician/Patient Relationship Through Enhanced Communication Channels and Improved Workflows 4Health News:Fingerprints May Vanish With Cancer Drug 2Health News:Sharing surgical lessons from the Canadian field hospital in Afghanistan 2Health News:Recondo Technology Wins Red Herring 100 North America Award 2
(Date:11/24/2009)...ire/--MAQUETCardiovascularLLC,aleadingproviderofca...gnedaguaranteedtwo-yearcontractwithNovation,oneoft...thesolesourceproviderofsurgicaldevicesforbeatinghe...nt,whichrunsthroughOctober31,2012,MAQUETCardiovasc...sanddisposablesuppliestothemembersofVHAInc.andUniv...
(Date:11/24/2009)...wire-FirstCall/--ZimmerHoldings,Inc.(NYSE: ZMH ;SI...AnnualPiperJaffrayHealthCareConferenceinNewYork,Ne..., AlivewebcastofthepresentationcanbeaccessedviaZim...mmer.com .Thewebcastwillbearchivedforreplayfollowi...ndedin1927andheadquarteredinWarsaw,Indiana,Zimmerd...
(Date:11/24/2009)...4/PRNewswire/--SatelliteHealthcare,oneofthenation,...ndamajorsponsorofnephrologyresearch,todayannounced...srallahinhisefforttosupporttheSanJosehomelessthisT...essfulcareerasachefforthepast20years.ButNasrallah,...gnosedwithEndStageRenalDisease(ESRD).Thediagnosisi...
Breaking Medicine Technology:MAQUET Cardiovascular Receives Guaranteed Two-Year Sole Source Contract From Novation for Beating Heart Surgical Devices 2MAQUET Cardiovascular Receives Guaranteed Two-Year Sole Source Contract From Novation for Beating Heart Surgical Devices 3Satellite Healthcare and Renal Disease Survivor Elias Nasrallah Join Forces to Support the Homeless This Holiday Season 2Country United symposium explores collaborative future of military medicine 58428 1Country United symposium explores collaborative future of military medicine 58428 2Country United symposium explores collaborative future of military medicine 58428 3Orgasms sexual health and attitudes about female genitals 58425 1Orgasms sexual health and attitudes about female genitals 58425 2Global public health the focus of scientific conference 10144 1Global public health the focus of scientific conference 10144 2
...b Trial to Examine Safety and Efficacy of DARA ver...rmacopeia,(Nasdaq: PCOP ), an innovator in the di...erapeutics, today announced the initiation of a Ph...ead internal product candidate.,This randomized, d...l-group study is designed to evaluate the compound...
...LE, Md., Feb. 29 A study reported in,the journal ... in the,Ciliary Neurotrophic Factor gene (CNTF) ma...study, conducted by Vanda Pharmaceuticals,Inc., in...ia who were,treated either with Fiapta(TM) (iloper...ntly under review with the FDA, or placebo.,Patien...
Other Medicine Technology:Pharmacopeia Initiates Second Phase 2 Hypertension Study with PS433540 (DARA) 2Pharmacopeia Initiates Second Phase 2 Hypertension Study with PS433540 (DARA) 3Pharmacopeia Initiates Second Phase 2 Hypertension Study with PS433540 (DARA) 4Genetic Variation Associated with Treatment Response in a Clinical Study of a New Atypical Antipsychotic Fiaptatm (iloperidone) 2Genetic Variation Associated with Treatment Response in a Clinical Study of a New Atypical Antipsychotic Fiaptatm (iloperidone) 3
ScanGel® Incubator
... up to 12 mini gels under identical conditions in ... a time with the new Model 485 gradient former and... sources of variation and improving reproducibilit... convenience and reproducibility demanded by highe...
... up to 12 mini gels under identical conditions in ... a time with the new Model 485 gradient former and... sources of variation and improving reproducibilit... convenience and reproducibility demanded by highe...
...is system mirrors a 96-well plate in format, allow...ducts to take place easily and with direct compati...be carried out directly with a multi-channel pipet... off-set marker lanes are also included (one on ea...
Medicine Products: